The Discounted Cash Flow (DCF) valuation of Clinigen Group PLC (CLIN.L) is 559.41 GBP. With the latest stock price at 925.00 GBP, the upside of Clinigen Group PLC based on DCF is -39.5%.
Based on the latest price of 925.00 GBP and our DCF valuation, Clinigen Group PLC (CLIN.L) is a sell. selling CLIN.L stocks now will result in a potential gain of 39.5%.
Range | Selected | |
WACC / Discount Rate | 7.1% - 9.0% | 8.0% |
Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
Fair Price | 387.36 - 888.89 | 559.41 |
Upside | -58.1% - -3.9% | -39.5% |